BME is a mutual fund — prices shown are end-of-day NAV. Analyst ratings, insider activity, and 13F data apply to individual stocks, not funds.
BlackRock Health Sciences Trust
BME
NYSE·Financial Services·Asset Management·Mkt cap $512.6M
$45.81
▼ -0.43%
P/E
6.07
Mkt Cap
$512.6M
52-Wk Range
$35.95–$46.43
52-Week Range
$35.95 - $46.43
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
No thesis available for this stock yet.
Smart-money signal
Who's buying BME right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Most recent quarter reported revenue of $22.7M (-38% YoY). Reported EPS of $6.23. Gross margin 87.5%.
Reported EPS · last 4Q
Q4 25
$6.23
Q2 25
-$0.28
Q4 24
-$1.70
Q2 24
$3.30
Revenue trend · last 6Q
—
—
-102%
+101%
-76%
-38%
Q2 23
Q4 23
Q2 24
Q4 24
Q2 25
Q4 25
$16.6M
$18.3M
-$383.9K
$36.7M
$4.0M
$22.7M
Margins · last 6Q
Gross
87.5%
Operating
—
Profit
354.3%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How BME stacks vs Asset Management
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related